EditorialFree The Cancer Letter receives 7 journalism, design awards June 17, 2022Vol.48 No.24By Katie Goldberg
Guest Editorial ASCO’s “rock concert” moments came 17 years apart—in 2005 and 2022DESTINY-04 results extend HER2-targeted therapy to a larger population in breast cancer June 10, 2022Vol.48 No.23By George W. Sledge Jr.
In early results “unprecedented in rectal cancer,” 14/14 patients show clinical complete response to dostarlimab June 10, 2022Vol.48 No.23By Alice Tracey
Lowy calls for expanding NCI’s clinical impact, including: (1) the number of drug candidates, (2) the clinical trials system, and (3) access to cancer care June 10, 2022Vol.48 No.23By Alice Tracey
FreeObituary Moffitt’s Robert Gillies, “father of radiomics,” dies at 69 June 10, 2022Vol.48 No.23By Kim Polacek
FreeObituary Lucius Sinks, a giant in pediatric cancer, dies at 91“We were able to come together at Roswell Park and help the kids.” June 10, 2022Vol.48 No.23By Tim Wendel
FreeObituary Lucius Sinks was the type of physician all of us would like to have June 10, 2022Vol.48 No.23By Jerome Yates
FreeLetter To The Editor Tom Jordan: I wish to be known for Taxol, carboplatin, and camaraderie June 10, 2022Vol.48 No.23By Thomas D. Jordon
FreeIn the Archives How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission June 10, 2022Vol.48 No.23By Deborah Doroshow and Alexandria Carolan
Cancer History ProjectFree #MyFirstASCO: Memories from 57 years of annual meetings June 03, 2022Vol.48 No.22By Alexandria Carolan and Katie Goldberg
